Endoscopy Procedures Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD),

Endoscopy Procedures Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Procedures [Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Submucosal Dissection (ESD), Peroral Endoscopic Myotomy (POEM), Endoscopic Ultrasound (EUS), Interventional Pulmonology and Laparoscopy, Arthroscopy and Bronchoscopy, Colonoscopy and Colposcopy, Proctoscopy and Thoracoscopy, and Others], Offering [Endoscopes, ERCP Accessories, Head positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound (EUS) Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation tubing systems, Probes, Hemostasis Clip, Polyp Traps, Single-Use Valves , Trocar sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others (Kits/Stents/Energy Devices/ Transport pad/Cleaning Brush/OT Lights, etc.)], Product Type (Disposable and Reusable), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

The global endoscopy procedure market is expected to reach US$ 53,196.65 million in 2030 from US$ 30,877.37 million in 2022. The market is estimated to grow with a CAGR of 7.0% from 2022 to 2030.

The key factors that are driving the growth of market are growing preference for minimally invasive surgeries and the increasing prevalence of chronic diseases. However, the risks of infections associated with endoscopic procedures hamper the market growth.

Technological Advancement Leading to Enhanced Applications Opportunity for Growth of Endoscopy Procedure Market

The field of endoscopy in North America has witnessed various technological advancements and product launches. Such advancements are not only expected to help in the accurate diagnosis of a condition but also will help improve the safety of endoscopic procedures. Some recent technological advancements and product launches are listed below:

In April 2021, Olympus announced the addition to its U.S. bronchoscopy portfolio of the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a line of five premium endoscopes for use in advanced diagnostic and therapeutic procedures. The introduction of the H-SteriScope portfolio has been a collaboration between Veran Medical Technologies, Inc., a wholly owned Olympus subsidiary, and Hunan Vathin Medical Instrument Co., Ltd.

In April 2021, Ambu Inc. received Health Canada authorization for the aScope 4 Cysto, the company's unique flexible cystoscope platform for urology. Ambu’s aScope 4 Cysto is a cost-effective, high-quality flexible endoscope featuring excellent maneuverability and optics. Unlike traditional reusable endoscopes, single-use eliminates the significant capital, repair, and cleaning costs required to ensure a patient-ready instrument for every procedure. Each aScope 4 cystoscope is sterile from the package and ready when needed, enabling facilities to improve workflow efficiencies and reallocate staff from complex, time-consuming endoscope cleaning to more productive activities.

In December 2021, Medtronic Canada ULC, a subsidiary of Medtronic plc, received a Health Canada license for the Hugo robotic-assisted surgery (RAS) system for use in urologic and gynecologic laparoscopic surgical procedures, which make up about half of all robotic procedures performed in Canada. A modular, multi-quadrant platform indicated for urologic surgical procedures and gynecologic laparoscopic surgical procedures, the Hugo RAS system combines wristed instruments, 3D visualization, and a cloud-based surgical video capture option in Touch Surgery Enterprise with dedicated support teams specializing in robotics program optimization, service, and training.

In November 2022, PENTAX Medical launched the new Performance Endoscopic Ultrasound (EUS) system, a combination of the new ARIETTA 65 PX ultrasound scanner and their best-in-class J10 Series Ultrasound Gastroscopes in Canada. The ARIETTA 65 PX Performance ultrasound scanner is built for the endoscopic ultrasound practitioner focused on productivity. The system delivers brilliant imaging and value through its combination with the J10 Series Ultrasound Gastroscopes to efficiently manage high case volumes with ease.

On April 12, 2021, Cosmo Pharmaceuticals NV announced the FDA approval of the GI Genius intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The device is the first of its kind to obtain the FDA approval through the De Novo application. The device operates in real time to assist the endoscopist in the detection of lesions, is very simple to use and is compatible with all endoscopes. Cosmo is the sole manufacturer.On December 2019, Boston Scientific Corporation launched “EXALT Model D” a Single-Use Duodenoscope for endoscopic retrograde cholangiopancreatography procedures. This is the world’s first single-use duodenoscope. The third generation EXALT Model D Single-Use Duodenoscope has incorporated a number of design updates based on physician feedback that are intended to improve the overall user experience.

Thus, all these recent developments are expected to provide growth opportunities for the market over the forecast period.

Procedure -Based Insights

The endoscopy procedures market, by procedure, is endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy, colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. In 2022, the arthroscopy and bronchoscopy segment held the largest share of the market. However, the endoscopic retrograde cholangiopancreatography (ERCP) segment is expected to grow at the fastest rate during the forecasted years.

Offering-Based Insights

The endoscopy procedures market, by offering, is segment into Endoscopes, ERCP Accessories, Visualization System, Head Positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation Tubing Systems, Probes, Hemostats Clip, Polyps Traps, Single-use Valves, Trocar Sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others. In 2022, the endoscopes segment held the largest share of the market. The ERCP Accessories segment is expected to grow at the fastest rate during the forecasted period.

Product Type-Based Insights

The endoscopy procedures market, by product type, is segment into disposable and reusable. The reusable segment held the largest share of the market in 2022 and disposable segment is expected to grow at the highest CAGR during the forecast period.

End User-Based Insights

The endoscopy procedures market, by end user, is segment into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and others. In 2022, the hospitals and clinics segment held the largest share of the market. However, diagnostic laboratories are expected to grow fastest during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the endoscopy procedure market are the FDA (Food and Drug Administration), EUA (Emergency Use Authorization), EMA (European Medicines Agency), and EPA (Environmental Protection Agency)